Skip to main content
logo
Bacil Pharma Limited (BOM:524516)
India flag India · Delayed Price · Currency is INR
12.30
+0.44 (3.71%)
At close: Aug 21, 2026

Bacil Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
177685610863234
Market Cap Growth
-67.20%12.33%607.73%166.97%-4.36%83.65%
Enterprise Value
171669610832833
Last Close Price
12.3047.7342.4914.635.485.73

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
20.2844.04150.92---
PB Ratio
0.712.762.407.102.942.76
P/TBV Ratio
0.712.762.407.102.942.76
P/FCF Ratio
24.8196.27152.16---
P/OCF Ratio
24.8196.27152.16---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/FCF Ratio
24.0194.03152.28---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
--0.010.080.020.03
Debt / FCF Ratio
--0.41---
Net Debt / Equity Ratio
-0.02-0.02-0.110.05-0.18-0.22
Net Debt / EBITDA Ratio
-2.3310.67-0.301.121.76
Net Debt / FCF Ratio
--0.80-6.72-19.641.350.07
Quick Ratio
-0.6816.920.377.876.49
Current Ratio
-0.6817.210.468.196.69
Return on Equity (ROE)
-6.19%3.03%-5.11%-8.77%-295.12%
Return on Assets (ROA)
--0.58%-1.18%-9.62%-9.37%-3.70%
Return on Invested Capital (ROIC)
-4.42%-1.04%-2.09%-17.40%-19.41%-13.92%
Return on Capital Employed (ROCE)
--1.00%-1.00%-15.60%-16.30%-13.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
4.93%2.27%0.66%-0.69%-3.16%-114.37%
FCF Yield
4.03%1.04%0.66%-0.03%-4.57%-118.79%
Buyback Yield / Dilution
--121.94%-6.92%1.47%-1.71%-0.99%